MARIA BOHN: Open Payments
NPI 1255766960 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 55 payments from 9 companies in 2025. Trend: 2023 $703 · 2024 $1,111 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $372 |
| Genentech USA, Inc. | 10 | $220 |
| GlaxoSmithKline, LLC. | 13 | $215 |
| Regeneron Healthcare Solutions, Inc. | 8 | $214 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| GENZYME CORPORATION | 1 | $24 |
| BioCryst US Sales Co., LLC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: FASENRA, DUPIXENT, Xolair, NUCALA, TEZSPIRE, NEFFY, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
